{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:52:56Z","timestamp":1793267576333,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nephrotic syndrome (NS) can occur as a paraneoplastic disorder in association with various types of carcinoma. However, paraneoplastic nephrotic syndrome (PNS) is often misdiagnosed as idiopathic nephrotic syndrome or as an adverse effect of oncology treatment, leading to delayed diagnosis and suboptimal treatment. The characteristics of NS associated with solid malignancies are not yet elucidated. We systematically summarized the clinical data for 128 cases of NS combined with solid malignancies with the aim of informing the clinical management of PNS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the PubMed database for articles published from the date of inception through to October 2023 using the following keywords: \u201ccancer\u201d or \u201cmalignant neoplasms\u201d or \u201cneoplasia\u201d or \u201ctumors\u201d and \u201cnephrotic syndrome\u201d, \u201cnephrotic\u201d or \u201csyndrome, nephrotic\u201d. All data were extracted from case reports and case series, and the extraction included a method for identifying individual-level patient data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A literature search yielded 105 cases of PNS and 23 of NS induced by cancer therapy. The median age at diagnosis was 60 years, with a male to female ratio of 1.8:1. In patients with PNS, manifestations of NS occurred before, concomitantly with, or after diagnosis of the tumor (in 36%, 30%, and 34% of cases, respectively). Membranous nephropathy (49%) was the most prevalent renal pathology and found particularly in patients with lung, colorectal, or breast carcinoma. Regardless of whether treatment was for cancer alone or in combination with NS, the likelihood of remission was high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The pathological type of NS may be associated with specific malignancies in patients with PNS. Prompt identification of PNS coupled with suitable therapeutic intervention has a significant impact on the outcome for patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-024-03632-9","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T12:02:34Z","timestamp":1720094554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nephrotic syndrome associated with solid malignancies: a systematic review"],"prefix":"10.1186","volume":"25","author":[{"given":"Shuo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"3632_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127:3029\u201330. https:\/\/doi.org\/10.1002\/cncr.33587","journal-title":"Cancer"},{"key":"3632_CR2","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00011-023-01780-6","volume":"72","author":"M Zhao","year":"2023","unstructured":"Zhao M, Mi L, Ji Y, He X, Gao Y, Hu Y, Xu K. Advances of autoimmune rheumatic diseases related to malignant tumors. Inflamm Res. 2023;72:1965\u201379. https:\/\/doi.org\/10.1007\/s00011-023-01780-6","journal-title":"Inflamm Res"},{"key":"3632_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4103\/ams.ams_121_13","volume":"11","author":"S Ragulan","year":"2021","unstructured":"Ragulan S, Walker T, Modayil P, Odutoye B, Lee M. Hematological paraneoplastic syndrome and heparin-induced thrombocytopenia in untreated parotid acinic cell carcinoma - a case report. Ann Maxillofac Surg. 2021;11:152\u20135. https:\/\/doi.org\/10.4103\/ams.ams_121_13","journal-title":"Ann Maxillofac Surg"},{"key":"3632_CR4","first-page":"479","volume":"93","author":"C Kodner","year":"2016","unstructured":"Kodner C. Nephrotic syndrome in adults: diagnosis and management. Am Fam Physician. 2016;93:479\u201385.","journal-title":"Am Fam Physician"},{"key":"3632_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ki.2012.484","volume":"84","author":"KD Jhaveri","year":"2013","unstructured":"Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney Int. 2013;84:34\u201344. https:\/\/doi.org\/10.1038\/ki.2012.484","journal-title":"Kidney Int"},{"key":"3632_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/10428190290021443","volume":"43","author":"I Levi","year":"2002","unstructured":"Levi I, Dinour D, Ben-Bassat I, Raanani P. Acute myeloid leukemia associated with nephrotic syndrome: case report and literature review. Leuk Lymphoma. 2002;43:1133\u20136. https:\/\/doi.org\/10.1080\/10428190290021443","journal-title":"Leuk Lymphoma"},{"key":"3632_CR7","first-page":"343","volume":"77","author":"JM Wang","year":"2013","unstructured":"Wang JM, Li X. A 78-year-old man with rapidly-progressing sarcomatoid renal cell carcinoma. Conn Med. 2013;77:343\u20136.","journal-title":"Conn Med"},{"key":"3632_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.gcb.2010.08.001","volume":"34","author":"S de Decker","year":"2010","unstructured":"de Decker S, Bovy C, Deflandre J, Moonen M, Van Nes MC. Treatment of a nephrotic syndrome by endoscopic removal of a villous adenoma of the duodenum. Gastroenterol Clin Biol. 2010;34:625\u20138. https:\/\/doi.org\/10.1016\/j.gcb.2010.08.001","journal-title":"Gastroenterol Clin Biol"},{"key":"3632_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/j.ackd.2022.02.009","volume":"29","author":"A Jeyabalan","year":"2022","unstructured":"Jeyabalan A, Trivedi M. Paraneoplastic glomerular diseases. Adv Chronic Kidney Dis. 2022;29:116\u201326. https:\/\/doi.org\/10.1053\/j.ackd.2022.02.009","journal-title":"Adv Chronic Kidney Dis"},{"key":"3632_CR10","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","volume":"69","author":"V Audard","year":"2006","unstructured":"Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006;69:2251\u201360. https:\/\/doi.org\/10.1038\/sj.ki.5000341","journal-title":"Kidney Int"},{"key":"3632_CR11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/s0140-6736(71)91860-5","volume":"1","author":"WS Lowry","year":"1971","unstructured":"Lowry WS, Munzenrider JE, Lynch GA. Nephrotic syndrome in Hodgkin\u2019s disease. Lancet. 1971;1:1127. https:\/\/doi.org\/10.1016\/s0140-6736(71)91860-5","journal-title":"Lancet"},{"key":"3632_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/cncr.22904","volume":"110","author":"V Launay-Vacher","year":"2007","unstructured":"Launay-Vacher V, Oudard S, Janus N, Gligorov J, Pourrat X, Rixe O, Morere JF, Beuzeboc P, Deray G, Renal I, Cancer medications Study G. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer. 2007;110:1376\u201384. https:\/\/doi.org\/10.1002\/cncr.22904","journal-title":"Cancer"},{"key":"3632_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.amjmed.2014.05.002","volume":"127","author":"CF Christiansen","year":"2014","unstructured":"Christiansen CF, Onega T, Svaerke C, Kormendine Farkas D, Jespersen B, Baron JA, Sorensen HT. Risk and prognosis of cancer in patients with nephrotic syndrome. Am J Med. 2014;127:871\u20137. https:\/\/doi.org\/10.1016\/j.amjmed.2014.05.002","journal-title":"Am J Med"},{"key":"3632_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","volume":"56","author":"PM Ronco","year":"1999","unstructured":"Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355\u201377. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00548.x","journal-title":"Kidney Int"},{"key":"3632_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","volume":"70","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2009;70:39\u201358. https:\/\/doi.org\/10.1016\/j.critrevonc.2008.08.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"3632_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrneph.2010.171","volume":"7","author":"YH Lien","year":"2011","unstructured":"Lien YH, Lai LW. Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis. Nat Rev Nephrol. 2011;7:85\u201395. https:\/\/doi.org\/10.1038\/nrneph.2010.171","journal-title":"Nat Rev Nephrol"},{"key":"3632_CR17","first-page":"12","volume":"62","author":"M W\u0105growska-Danilewicz","year":"2011","unstructured":"W\u0105growska-Danilewicz M, Danilewicz M. Nephrotic syndrome and neoplasia: our experience and review of the literature. Pol J Pathol. 2011;62:12\u20138.","journal-title":"Pol J Pathol"},{"key":"3632_CR18","doi-asserted-by":"publisher","first-page":"886","DOI":"10.2215\/CJN.09000819","volume":"15","author":"E Plaisier","year":"2020","unstructured":"Plaisier E, Ronco P. Screening for cancer in patients with glomerular diseases. Clin J Am Soc Nephrol. 2020;15:886\u20138. https:\/\/doi.org\/10.2215\/CJN.09000819","journal-title":"Clin J Am Soc Nephrol"},{"key":"3632_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7150\/jca.16550","volume":"8","author":"CC Chien","year":"2017","unstructured":"Chien CC, Han MM, Chiu YH, Wang JJ, Chu CC, Hung CY, Sun YM, Yeh NC, Ho CH, Lin CC, Kao HY, Weng SF. Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan. J Cancer. 2017;8:9\u201318. https:\/\/doi.org\/10.7150\/jca.16550","journal-title":"J Cancer"},{"key":"3632_CR20","first-page":"232","volume":"17","author":"P Zech","year":"1982","unstructured":"Zech P, Colon S, Pointet P, Deteix P, Labeeuw M, Leitienne P. The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. Clin Nephrol. 1982;17:232\u20136.","journal-title":"Clin Nephrol"},{"key":"3632_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2169\/internalmedicine.50.4341","volume":"50","author":"C Ito","year":"2011","unstructured":"Ito C, Akimoto T, Nakazawa E, Komori S, Sugase T, Chinda J, Takahashi H, Ioka T, Muto S, Kusano E. A case of cervical cancer-related membranous nephropathy treated with radiation therapy. Intern Med. 2011;50:47\u201351. https:\/\/doi.org\/10.2169\/internalmedicine.50.4341","journal-title":"Intern Med"},{"key":"3632_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000045542","volume":"84","author":"H Matsuura","year":"2000","unstructured":"Matsuura H, Sakurai M, Arima K. Nephrotic syndrome due to membranous nephropathy associated with metastatic prostate cancer: rapid remission after initial endocrine therapy. Nephron. 2000;84:75\u20138. https:\/\/doi.org\/10.1159\/000045542","journal-title":"Nephron"},{"key":"3632_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/030089160409000132","volume":"90","author":"F Valcamonico","year":"2004","unstructured":"Valcamonico F, Ferrari V, Simoncini E, Gregorini G, Vassalli L, Amoroso V, Marpicati P, Rangoni G, Mambrini A, Marini G. Paraneoplastic nephrotic syndrome in advanced breast cancer patient. A case report. Tumori. 2004;90:154\u20136. https:\/\/doi.org\/10.1177\/030089160409000132","journal-title":"Tumori"},{"key":"3632_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1159\/000188527","volume":"69","author":"K Hiromura","year":"1995","unstructured":"Hiromura K, Fukushima Y, Tsukada Y, Kanai H, Maezawa A, Yano S, Naruse T. Nephrotic syndrome associated with liver metastasis of rectal cancer. Nephron. 1995;69:485\u20136. https:\/\/doi.org\/10.1159\/000188527","journal-title":"Nephron"},{"key":"3632_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3349\/ymj.2003.44.3.539","volume":"44","author":"YT Kim","year":"2003","unstructured":"Kim YT, Rha SY, Shim CY, Sohn JH, Kim C, Yu NC, Chung HC, Kim JH, Han DS, Kim BS, Roh JK. A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma. Yonsei Med J. 2003;44:539\u201343. https:\/\/doi.org\/10.3349\/ymj.2003.44.3.539","journal-title":"Yonsei Med J"},{"key":"3632_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2169\/internalmedicine.48.1292","volume":"48","author":"T Muramoto","year":"2009","unstructured":"Muramoto T, Kaneko K, Kuroki A, Konishi K, Ito H, Katagiri A, Kubota Y, Ohtsu A, Imawari M. Causal relationships between esophageal squamous cell carcinoma and nephrotic syndrome. Intern Med. 2009;48:65\u20139. https:\/\/doi.org\/10.2169\/internalmedicine.48.1292","journal-title":"Intern Med"},{"key":"3632_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jclinpath-2019-205852","volume":"72","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhang M, Chen D, Ren Q, Xu W, Zeng C, Qin W, Liu Z. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy. J Clin Pathol. 2019;72:705\u201311. https:\/\/doi.org\/10.1136\/jclinpath-2019-205852","journal-title":"J Clin Pathol"},{"key":"3632_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa0810457","journal-title":"N Engl J Med"},{"key":"3632_CR29","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1186\/s12885-015-1937-y","volume":"15","author":"M Menschikowski","year":"2015","unstructured":"Menschikowski M, Hagelgans A, Nacke B, Jandeck C, Sukocheva O, Siegert G. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells. BMC Cancer. 2015;15:971. https:\/\/doi.org\/10.1186\/s12885-015-1937-y","journal-title":"BMC Cancer"},{"key":"3632_CR30","doi-asserted-by":"publisher","first-page":"e104936","DOI":"10.1371\/journal.pone.0104936","volume":"9","author":"Y Du","year":"2014","unstructured":"Du Y, Li J, He F, Lv Y, Liu W, Wu P, Huang J, Wei S, Gao H. The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis. PLoS ONE. 2014;9:e104936. https:\/\/doi.org\/10.1371\/journal.pone.0104936","journal-title":"PLoS ONE"},{"key":"3632_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ki.2012.209","volume":"82","author":"E Hoxha","year":"2012","unstructured":"Hoxha E, Kneissler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012;82:797\u2013804. https:\/\/doi.org\/10.1038\/ki.2012.209","journal-title":"Kidney Int"},{"key":"3632_CR32","doi-asserted-by":"publisher","unstructured":"Zhang P, Huang W, Zheng Q, Tang J, Dong Z, Jiang Y, Liu Y, Liu W. A novel insight into the role of PLA2R and THSD7A in membranous nephropathy. J Immunol Res. 2021;2021(8163298). https:\/\/doi.org\/10.1155\/2021\/8163298","DOI":"10.1155\/2021\/8163298"},{"key":"3632_CR33","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/modpathol.2017.163","volume":"31","author":"SG Sharma","year":"2018","unstructured":"Sharma SG, Larsen CP. Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study. Mod Pathol. 2018;31:616\u201322. https:\/\/doi.org\/10.1038\/modpathol.2017.163","journal-title":"Mod Pathol"},{"key":"3632_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","volume":"97","author":"S Sethi","year":"2020","unstructured":"Sethi S, Debiec H, Madden B, Charlesworth MC, Morelle J, Gross L, Ravindran A, Buob D, Jadoul M, Fervenza FC, Ronco P. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int. 2020;97:163\u201374. https:\/\/doi.org\/10.1016\/j.kint.2019.09.014","journal-title":"Kidney Int"},{"key":"3632_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.1977.47","volume":"11","author":"JW Eagen","year":"1977","unstructured":"Eagen JW. Glomerulopathies of neoplasia. Kidney Int. 1977;11:297\u2013303. https:\/\/doi.org\/10.1038\/ki.1977.47","journal-title":"Kidney Int"},{"key":"3632_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/B978-0-7020-4086-3.00026-6","volume":"119","author":"DS Liebeskind","year":"2014","unstructured":"Liebeskind DS. Nephrotic syndrome. Handb Clin Neurol. 2014;119:405\u201315. https:\/\/doi.org\/10.1016\/B978-0-7020-4086-3.00026-6","journal-title":"Handb Clin Neurol"},{"key":"3632_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11906-007-0058-7","volume":"9","author":"M Jain","year":"2007","unstructured":"Jain M, Townsend RR. Chemotherapy agents and hypertension: a focus on angiogenesis blockade. Curr Hypertens Rep. 2007;9:320\u20138. https:\/\/doi.org\/10.1007\/s11906-007-0058-7","journal-title":"Curr Hypertens Rep"},{"key":"3632_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2215\/CJN.12771211","volume":"7","author":"RJ Glassock","year":"2012","unstructured":"Glassock RJ. Attending rounds: an older patient with nephrotic syndrome. Clin J Am Soc Nephrol. 2012;7:665\u201370. https:\/\/doi.org\/10.2215\/CJN.12771211","journal-title":"Clin J Am Soc Nephrol"},{"key":"3632_CR39","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1186\/1752-1947-3-7248","volume":"3","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta J, Ranch\u00e8re D, Dijoud F, Droz JP. Mesothelioma of the testis and nephrotic syndrome: a case report. J Med Case Rep. 2009;3:7248. https:\/\/doi.org\/10.1186\/1752-1947-3-7248","journal-title":"J Med Case Rep"},{"key":"3632_CR40","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00595-004-2811-8","volume":"34","author":"Y Kijima","year":"2004","unstructured":"Kijima Y, Yoshinaka H, Owaki T, Nozaki T, Hamada T, Yasumoto Y, Aikou T. Breast cancer with nephrotic syndrome: report of two cases. Surg Today. 2004;34:755\u20139. https:\/\/doi.org\/10.1007\/s00595-004-2811-8","journal-title":"Surg Today"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03632-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03632-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03632-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T12:05:05Z","timestamp":1720094705000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03632-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03632-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"18 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This scoping review is a synthesis of existing literature. Ethics approval and consent to participate are therefore not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"215"}}